Skip to content
Home/Companies/Biotech/Baseimmune
BA

Baseimmune

Biotech·UK·Active·5yr hold

Baseimmune is a biotech company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Baseimmune?

Baseimmune is currently owned by IQ Capital Partners through IQ Capital Fund III (2018 vintage), since 2021.

Hand-verified · updated 2026-07-08

IQ Capital Partners
Investor
IQ Capital Partners
IQ Capital Fund III · 2018 · VC

Key facts

HQUK
SectorBiotech
StatusActive

More from IQ Capital Fund III

Other portfolio companies in the same fund.

Trogenix
Active
BiotechUK· 2023
IONATE
Active
ClimateTechUK· 2022
Tropic Biosciences
Active
AgTechUK· 2022
Cambridge GaN Devices
Active
Deep TechUK· 2021
Foundries.io
Exited 2024
DevToolsUK· 2021
to
NanoSyrinx
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings